The future of synthetic biology will depend not only on the ability to design biological systems, but on the capacity to manufacture DNA reliably at scale within regulated frameworks.
Thomas Ybert
Advertisement
Dr. Thomas Ybert is chief scientific officer and co-founder of DNA Script and leads the company's research and innovation efforts. Thomas is the main inventor of DNA Script's Enzymatic DNASynthesis (EDS) technology. Holding a PhD in molecular biology and yeast genetics from Ecole Polytechnique, his background includes R&D roles at Sanofi and Total/Amyris.
Articles by Thomas Ybert
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Updates Master Protocol: What Developers Need to Know
2
Pharma Fundamentals: Hold Times in Biopharmaceuticals
3
Merck KGaA Launches Saturnus Bio; Announces Awards
4
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
5